Skip to content
Home » Stone » Stones in pregnancy

Stones in pregnancy

Variable incidence depending on source – between 1 in 200 and 1 in 1500.

Overall incidence appears similar to non-pregnant women of similar ages.

Most patients present in second and third trimester.

Physiological changes in pregnancy contributing to stone formation:

  • Increased vitamin D levels (placental production) -> hypercalciuria
  • Increased renal blood and GFR -> increased filtered solute load
    • Increased urinary concentration of stone inhibitors (citrate and Mg)
    • Increased urinary calcium and glucose
    • Increased urine volumes (preventative)
  • Stasis and increased renal pelvis pressures due to physiological hydronephrosis
  • Elevated urine pH (calcium phosphate stones most common in pregnant women)

 

Physiological changes leading to hydronephrosis:

  • Increased renal blood flow, with GFR increasing by 50 % and increased urine output
  • Mechanical compression of pelvis and retroperitoneum causing dilation of collecting systems, right > left
  • Higher levels of progesterone causes smooth muscle relaxation
  • Right sided more common due to gravid uterus dextro-rotation, left side protected by gas filled sigmoid, and potentially right ureter compressed by dilated right gonadal vein
    • Right sided dilation in up to 90 % by end of third trimester
    • Historically average 15 mm right sided pelvicalyceal dilation, 5 mm on left

 

Management principles:

  • Multidisciplinary care shared with obstetrician
  • Consider alternate diagnoses as causes of pain (appendicitis, pyelonephritis, colitis)
  • Observation and conservative management should be first line in the absence of infection and uncontrolled pain
  • Attempt to avoid risks to pregnancy – i.e., ionising radiation, risks of anaesthesia, risks of sepsis
  • Management should be undertaken in a centre with both urological and obstetric capability

 

Investigation of women with loin pain:

  • History – loin pain, symptoms of infection, history of UTIs, haematuria and urinary symptoms, obstetric history and complicating features
  • Examination – vital signs, flank tenderness, health of child
  • Blood tests including renal function
  • Urine analysis – blood, nitrites, leukocytes

Ultrasound is first line imaging modality

  • Operator dependent
  • Renal pelvis, proximal ureteric and VUJ stones may be visible; not mid ureteric
  • Ureteric jet may be useful
  • Resistance index

MRI is second line – indicated if concerns for ureteric stone not elucidated on ultrasound

  • No radiation
  • Non contrast
  • May be difficult to access
  • Stones visualised as filling defects in the high intensity signal of urine on T2

CT has best sensitivity and specificity but its use is limited by radiation dose, however:

  • Radiation exposure from non contrast CT is much lower than exposure associated with foetal harm
  • Radiation doses < 50 mGy considered safe in pregnancy
  • Risk minimised in third trimester
  • Should be used as last line imaging

 

Management of symptomatic stones

In the presence of infection -> ureteric stent.

In the presence of symptoms:

  • Conservative management preferred in the absence of strong indications for intervention
    • Alpha blockers have not been studied in pregnancy
    • 70 – 80 % stones can be successfully managed conservatively
  • Stent (or nephrostomy) which can be maintained during pregnancy, then proceeding to definitive ureteroscopy after pregnancy
  • Primary ureteroscopy and laser of stone

ESWL is contra-indicated.

PCNL has only limited evidence and should rarely be needed in individualised cases in experienced centres.

Nephrostomy is a reasonable alternative to stenting:

  • Can be done without GA
  • Can be done with radiation under ultrasound, and changed in the same way without GA or ultrasound

Ureteric stents tend to encrust quicker in pregnancy due to hypercalciuria and hyperuricosuria:

  • Stents often poorly tolerated with significant analgesia requirements
  • Reduced quality of life
  • May require frequent changes 4 – 8 weekly (with risks associated each time)
  • May be nidus for bacteriuria and subsequent complicated UTIs/sepsis

Principles of operating on pregnant women:

  • Defer operating if possible – but – do not withhold necessary surgery just because a woman is pregnant
  • Multidisciplinary decision making with obstetricians and anaesthetics
  • Consider elevating right side to reduce caval compression which reduces venous return
  • Remember significantly higher VTE risk in pregnant women.
  • Foetal Doppler/monitoring is usually used pre and post-operatively to exclude complication and reassure mother
  • GA can theoretically risk pre-term labour although these risks are small in absolute terms
  • Avoid excess stimulation of cervix during prep
  • Consider omitting fluoroscopy, using ultrasound to check stent placement if available
  • Second trimester is optimal time to operate (avoid risk of inducing labour)
  • No anaesthetic agents seem to have teratogenic effects
  • Operations should be done at hospitals with appropriate neonatal and obstetric services, and obstetricians should be aware the procedure is happening and available if needed
  • Avoid high pressures if operating laparoscopically (aim < 15 mm Hg).

NSAIDs are generally contra-indicated in pregnancy, especially after 20 – 30 weeks.

Penicillins and cephalosporins safe in pregnancy. Gentamicin also commonly used.

Fluoroquinolones contra-indicated. Bactrim/trimethoprim contra-indicated in first trimester (folic acid inhibitor). Nitrofurantoin contra-indicated in third trimester.